EGFR and adenocarcinoma: However, BM was common in female patients (p = 0.015), those who had never smoked (p < 0.001), and patients with adenocarcinoma histology (p = 0.003), EGFR activating mutations (p = 0.013), and bone metastasis (p < 0.001).